Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.
COVID-19
SARS-CoV-2
anti-glycan antibodies
antibody-dependent enhancement
natural antibodies
virus-neutralizing activity
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
20 07 2023
20 07 2023
Historique:
received:
21
06
2023
revised:
17
07
2023
accepted:
18
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Antibody-dependent enhancement (ADE) is a phenomenon where virus-specific antibodies paradoxically cause enhanced viral replication and/or excessive immune responses, leading to infection exacerbation, tissue damage, and multiple organ failure. ADE has been observed in many viral infections and is supposed to complicate the course of COVID-19. However, the evidence is insufficient. Since no specific laboratory markers have been described, the prediction and confirmation of ADE are very challenging. The only possible predictor is the presence of already existing (after previous infection) antibodies that can bind to viral epitopes and promote the disease enhancement. At the same time, the virus-specific antibodies are also a part of immune response against a pathogen. These opposite effects of antibodies make ADE research controversial. The assignment of immunoglobulins to ADE-associated or virus neutralizing is based on their affinity, avidity, and content in blood. However, these criteria are not clearly defined. Another debatable issue (rather terminological, but no less important) is that in most publications about ADE, all immunoglobulins produced by the immune system against pathogens are qualified as pre-existing antibodies, thus ignoring the conventional use of this term for natural antibodies produced without any stimulation by pathogens. Anti-glycan antibodies (AGA) make up a significant part of the natural immunoglobulins pool, and there is some evidence of their antiviral effect, particularly in COVID-19. AGA have been shown to be involved in ADE in bacterial infections, but their role in the development of ADE in viral infections has not been studied. This review focuses on pros and cons for AGA as an ADE trigger. We also present the results of our pilot studies, suggesting that AGAs, which bind to complex epitopes (glycan plus something else in tight proximity), may be involved in the development of the ADE phenomenon.
Identifiants
pubmed: 37515270
pii: v15071584
doi: 10.3390/v15071584
pmc: PMC10384250
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Antibodies, Neutralizing
0
Epitopes
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Nat Commun. 2020 May 4;11(1):2251
pubmed: 32366817
Front Immunol. 2018 Apr 23;9:597
pubmed: 29740424
Mayo Clin Proc. 2020 Sep;95(9):1888-1897
pubmed: 32861333
Jpn J Infect Dis. 2015;68(1):45-9
pubmed: 25420650
Glycobiology. 2014 Jul;24(7):602-18
pubmed: 24727442
J Immunol. 1989 Oct 15;143(8):2595-601
pubmed: 2507634
Hong Kong Med J. 2016 Jun;22(3 Suppl 4):25-31
pubmed: 27390007
BMJ Glob Health. 2020 Jun;5(6):
pubmed: 32532758
Trends Immunol. 2003 Sep;24(9):465-7
pubmed: 12967664
Front Immunol. 2021 Feb 24;12:640093
pubmed: 33717193
Immunol Rev. 2015 Nov;268(1):340-64
pubmed: 26497532
Virol Sin. 2017 Feb;32(1):16-22
pubmed: 27853992
Sci Rep. 2016 Jul 06;6:29201
pubmed: 27380892
J Infect Dis. 2020 May 11;221(11):1762-1769
pubmed: 32227123
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
Clin Infect Dis. 2021 Jul 15;73(2):328-331
pubmed: 32750119
Front Immunol. 2019 Jan 29;10:90
pubmed: 30761148
Mol Immunol. 2020 Apr;120:74-82
pubmed: 32087569
Cells. 2020 Aug 25;9(9):
pubmed: 32854433
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Diabetes Metab Res Rev. 2021 Feb;37(2):e3377
pubmed: 32588943
Microbiol Spectr. 2016 Nov;4(6):
pubmed: 27809953
Physiol Genomics. 2004 Jul 08;18(2):245-8
pubmed: 15161967
Nat Microbiol. 2020 Oct;5(10):1185-1191
pubmed: 32908214
Front Immunol. 2022 Apr 04;13:882972
pubmed: 35444667
Trends Microbiol. 2016 Dec;24(12):933-943
pubmed: 27751627
Lancet Microbe. 2020 Aug;1(4):e151
pubmed: 33521716
J Med Virol. 2006 Jan;78(1):1-8
pubmed: 16299724
Viruses. 2022 May 25;14(6):
pubmed: 35746613
Nature. 2020 Aug;584(7821):353-363
pubmed: 32659783
Tissue Antigens. 2005 Oct;66(4):291-6
pubmed: 16185324
J Indian Inst Sci. 2022;102(2):671-687
pubmed: 35136306
Emerg Microbes Infect. 2020 Dec;9(1):558-570
pubmed: 32172672
Clin Rev Allergy Immunol. 2020 Apr;58(2):213-228
pubmed: 31161341
J Med Virol. 2022 Jan;94(1):388-392
pubmed: 34415572
Semin Immunopathol. 2016 Jul;38(4):471-82
pubmed: 26965109
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830861
PLoS One. 2015 Jul 24;10(7):e0132122
pubmed: 26208004
Transfusion. 2021 Apr;61(4):1171-1180
pubmed: 33590501
J Virol. 2021 Jul 26;95(16):e0061721
pubmed: 34105996
Int J Infect Dis. 2020 Nov;100:483-489
pubmed: 32920233
World J Gastroenterol. 2008 Jul 21;14(27):4352-8
pubmed: 18666325
Anal Bioanal Chem. 2021 Dec;413(29):7179-7193
pubmed: 34235568
Lancet. 2019 Jan 26;393(10169):350-363
pubmed: 30696575
Microbes Infect. 2020 Mar;22(2):72-73
pubmed: 32092539
Top Curr Chem. 2015;366:169-81
pubmed: 24037491
Mil Med Res. 2021 Aug 31;8(1):47
pubmed: 34465396
AIDS. 2019 Nov 1;33(13):1961-1966
pubmed: 31373915
Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14
pubmed: 25073113
Arch Virol. 2016 Jul;161(7):1751-60
pubmed: 27068162
Viruses. 2020 May 08;12(5):
pubmed: 32397218
Curr Opin Virol. 2015 Apr;11:63-9
pubmed: 25747313
ACS Cent Sci. 2021 Apr 28;7(4):586-593
pubmed: 34056088
Clin Infect Dis. 2012 Nov;55(9):1188-97
pubmed: 22806596
Nature. 1980 Jun 12;285(5765):504-5
pubmed: 7402295
J Gen Virol. 2002 Sep;83(Pt 9):2091-2108
pubmed: 12185262
Expert Rev Anti Infect Ther. 2021 Dec;19(12):1495-1502
pubmed: 34182875
PLoS Pathog. 2019 Apr 18;15(4):e1007640
pubmed: 30998804
Biochemistry (Mosc). 2013 Jul;78(7):786-97
pubmed: 24010841
Cell Rep. 2020 Jun 2;31(9):107725
pubmed: 32426212
Immunol Cell Biol. 2007 Jan;85(1):43-5
pubmed: 17130899
Viruses. 2021 Sep 30;13(10):
pubmed: 34696397
J Mol Biol. 2003 Jan 31;325(5):979-89
pubmed: 12527303
Emerg Microbes Infect. 2021 Dec;10(1):774-781
pubmed: 33830901
J Virol. 2014 Jun;88(12):7045-53
pubmed: 24719424
J Biomed Sci. 2013 Jun 25;20:40
pubmed: 23800014
Front Cell Infect Microbiol. 2020 Oct 02;10:580096
pubmed: 33123500
PNAS Nexus. 2022 Jun 17;1(3):pgac062
pubmed: 35865361
Cell Res. 2010 Jan;20(1):34-50
pubmed: 20010915
Int J Infect Dis. 2021 Mar;104:242-249
pubmed: 33326874
Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):755-65
pubmed: 16820243
Biochem J. 2021 Apr 30;478(8):1485-1509
pubmed: 33881487
Front Immunol. 2021 Feb 03;11:594963
pubmed: 33613518
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
J Clin Virol. 2006 Feb;35(2):179-84
pubmed: 16112612
J Clin Invest. 1992 Apr;89(4):1223-35
pubmed: 1556184
Glycobiology. 2000 Jun;10(6):601-9
pubmed: 10814702
J Biol Chem. 2017 Mar 3;292(9):3900-3908
pubmed: 28077575
Mol Biol. 2020;54(6):812-826
pubmed: 32921819
Cell Host Microbe. 2008 Sep 11;4(3):229-38
pubmed: 18779049
Virology. 2017 Aug;508:1-6
pubmed: 28475924
J Vet Med Sci. 2019 Jun 21;81(6):911-915
pubmed: 31019150
Emerg Microbes Infect. 2020 Dec;9(1):1474-1488
pubmed: 32543348
Expert Rev Anti Infect Ther. 2017 Feb;15(2):111-119
pubmed: 27796143
Nat Commun. 2020 May 27;11(1):2688
pubmed: 32461612
Anal Chem. 2021 Feb 2;93(4):2003-2009
pubmed: 33406838
Cell Host Microbe. 2007 Mar 15;1(1):51-61
pubmed: 18005681
Science. 2017 Nov 17;358(6365):929-932
pubmed: 29097492
Front Genet. 2014 Aug 05;5:262
pubmed: 25147556
Front Immunol. 2023 Jun 02;14:1200195
pubmed: 37334355
Rev Med Virol. 2003 Nov-Dec;13(6):387-98
pubmed: 14625886
Virology. 2015 May;479-480:609-18
pubmed: 25812764
Hum Vaccin Immunother. 2020 Dec 1;16(12):3055-3060
pubmed: 32845733
PLoS Negl Trop Dis. 2020 May 28;14(5):e0008285
pubmed: 32463814
Nat Rev Immunol. 2020 Jun;20(6):339-341
pubmed: 32317716
Emerg Infect Dis. 2005 Nov;11(11):1730-7
pubmed: 16318725
J Virol. 2011 Oct;85(20):10582-97
pubmed: 21775467
Nat Rev Immunol. 2020 Oct;20(10):633-643
pubmed: 32782358
Nat Rev Immunol. 2011 Jul 15;11(8):532-43
pubmed: 21760609
Mol Immunol. 2009 Sep;46(15):3037-49
pubmed: 19608278
Biochemistry (Mosc). 2015 Jul;80(7):836-45
pubmed: 26541998
PLoS One. 2013 Jun 24;8(6):e66738
pubmed: 23826122
JAMA. 2005 Mar 23;293(12):1450-1
pubmed: 15784866
Am J Pathol. 2007 Apr;170(4):1136-47
pubmed: 17392154
Front Immunol. 2016 Jun 06;7:198
pubmed: 27375614
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2722-7
pubmed: 24550301
ACS Infect Dis. 2016 May 13;2(5):361-76
pubmed: 27627203
Sci Rep. 2016 Nov 16;6:37252
pubmed: 27849031
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Viruses. 2011 Oct;3(10):1909-32
pubmed: 22069522
Front Microbiol. 2021 Feb 11;12:641460
pubmed: 33643275
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
PLoS Pathog. 2011 Jun;7(6):e1002111
pubmed: 21738473
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211050199
pubmed: 34632844
Front Chem. 2021 Sep 06;9:689521
pubmed: 34552909
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033172
Viruses. 2014 Mar 14;6(3):1294-316
pubmed: 24638204
Infect Immun. 1995 Dec;63(12):4900-6
pubmed: 7591153
Annu Rev Microbiol. 2019 Sep 8;73:529-557
pubmed: 31226023
Can J Microbiol. 2021 Oct;67(10):687-702
pubmed: 34171205
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9036-40
pubmed: 1833770
Science. 2016 Aug 19;353(6301):823-6
pubmed: 27417494
Sci Rep. 2016 Jul 07;6:28768
pubmed: 27385443
Glycoconj J. 2011 Dec;28(8-9):501-5
pubmed: 22057658
Mol Biosyst. 2009 Oct;5(10):1087-104
pubmed: 19756298
Bioconjug Chem. 2021 Aug 18;32(8):1606-1616
pubmed: 34181851
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Eur J Intern Med. 2021 Nov;93:107-109
pubmed: 34598853
Front Microbiol. 2017 Jul 25;8:1415
pubmed: 28791003
Nat Biotechnol. 2020 Jul;38(7):789-791
pubmed: 32504046
Angew Chem Int Ed Engl. 2020 Dec 21;59(52):23763-23771
pubmed: 32915505
Carbohydr Res. 2011 May 1;346(6):828-32
pubmed: 21439556
Annu Rev Immunol. 2018 Apr 26;36:279-308
pubmed: 29345964
Arthritis Rheum. 2011 Mar;63(3):597-602
pubmed: 21360488
Front Microbiol. 2022 Jan 05;12:799519
pubmed: 35069504
Adv Biol. 2014;2014:
pubmed: 27099867
Cell Rep. 2021 Feb 2;34(5):108699
pubmed: 33485405
Virulence. 2022 Dec;13(1):670-683
pubmed: 35436420
Glycobiology. 2008 Dec;18(12):1085-93
pubmed: 18818423
PLoS Pathog. 2020 May 21;16(5):e1008556
pubmed: 32437478
J Virol. 2020 Feb 14;94(5):
pubmed: 31826992
Microbiol Mol Biol Rev. 2016 Oct 26;80(4):989-1010
pubmed: 27784796
J Immunol. 2012 Feb 1;188(3):939-45
pubmed: 22262757